680 filings
Page 5 of 34
8-K
RNAC
Cartesian Therapeutics Inc
13 Nov 23
Entry into a Material Definitive Agreement
9:02am
8-K
RNAC
Cartesian Therapeutics Inc
31 Oct 23
Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi
4:06pm
CORRESP
RNAC
Cartesian Therapeutics Inc
30 Oct 23
Correspondence with SEC
12:00am
UPLOAD
RNAC
Cartesian Therapeutics Inc
30 Oct 23
Letter from SEC
12:00am
S-3
RNAC
Cartesian Therapeutics Inc
Shelf registration
25 Oct 23
5:29pm
4
Carsten Brunn
26 Sep 23
SELECTA BIOSCIENCES / Carsten Brunn ownership change
6:01pm
4
Peter G Traber
26 Sep 23
SELECTA BIOSCIENCES / PETER G TRABER ownership change
6:00pm
8-K
RNAC
Cartesian Therapeutics Inc
25 Sep 23
Departure of Directors or Certain Officers
4:15pm
SC 13D/A
RNAC
Cartesian Therapeutics Inc
25 Sep 23
SELECTA BIOSCIENCES / SPRINGER TIMOTHY A ownership change
12:00am
8-K
RNAC
Cartesian Therapeutics Inc
13 Sep 23
Other Events
7:33am
S-8
RNAC
Cartesian Therapeutics Inc
17 Aug 23
Registration of securities for employees
7:23am
10-Q
2023 Q2
RNAC
Cartesian Therapeutics Inc
Quarterly report
17 Aug 23
7:13am
8-K
RNAC
Cartesian Therapeutics Inc
17 Aug 23
Results of Operations and Financial Condition
7:10am
NT 10-Q
RNAC
Cartesian Therapeutics Inc
14 Aug 23
Notice of late quarterly filing
7:00am
8-K
RNAC
Cartesian Therapeutics Inc
16 Jun 23
Submission of Matters to a Vote of Security Holders
4:20pm
DEFA14A
RNAC
Cartesian Therapeutics Inc
13 Jun 23
Additional proxy soliciting materials
7:54am
SC 13G
Artal International S.C.A.
12 Jun 23
SELECTA BIOSCIENCES / Artal International S.C.A. ownership change
4:30pm
4
RNAC
Cartesian Therapeutics Inc
1 Jun 23
SELECTA BIOSCIENCES / Takashi Kei Kishimoto ownership change
4:27pm
10-Q
2023 Q1
RNAC
Cartesian Therapeutics Inc
Quarterly report
4 May 23
7:35am
DEFA14A
RNAC
Cartesian Therapeutics Inc
28 Apr 23
Additional proxy soliciting materials
4:20pm